30.1 C
Delhi
Friday, April 12, 2024

WHO to drop HCQ from its global study into COVID-19 treatments: Dr Tedros

Date:

Share post:

Donate-GC-Razorpay

Geneva: The World Health Organisation (WHO) is to drop hydroxychloroquine from its global study into COVID-19 treatments. 

Speaking at the Global Media briefing today, Dr Tedros Adhanom Ghebreyesus, Director-General, WHO stated that in light of a paper published last week in The Lancet, that showed people taking hydroxychloroquine (HCQ) were at a higher risk of death and heart-related problems than those who were not taking HCQ. 

Dr Tedros revealed that the Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board

“The other arms of the trial are continuing. This concern relates to the use of hydroxychloroquine and chloraquine in #COVID19. I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria,” Dr Tedros expressed.

Related articles

Finding solace and resilience in Mohua Chinappa’s ‘If Only It Were Spring Every Day’

If you are yearning for love, respect and humanity, amidst all the chaos of the world, the collection...

No significant impact of Modi in K’taka: Home min Dr Parameshwara

Bengaluru: Confident of the Congress party's prospects in the upcoming Lok Sabha elections in Karnataka, Home Minister Dr....

Air India augments customer care with five new centres globally

Gurugram: Air India, India’s leading global airline, has deployed five new contact centres, offering round-the-clock assistance to its...

BJP files complaint with ECI against Shivakumar’s remarks targeting Vokkaliga sentiments

Bengaluru: The political atmosphere in Karnataka seems charged, with the BJP filing a complaint against Deputy Chief Minister...